Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Burkitt Lymphoma 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Biphenotypic, Acute 2Sarcoma, Myeloid 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1Down Syndrome 1

Interventions

Cyclophosphamide 5fludarabine phosphate 3Vincristine 3Methotrexate 3Etoposide 3pegaspargase 2merphos 2dexamethasone acetate 2dexamethasone 21-phosphate 2auricularum 2Whole-Body Irradiation 2Tacrolimus 2Specimen Handling 2Sirolimus 2Peripheral Blood Stem Cell Transplantation 2Leucovorin 2Doxorubicin 2Dexamethasone 2Cytarabine 2Calcium Dobesilate 2venetoclax 1prednylidene 1hydrocortisone hemisuccinate 1fludarabine 1exifone 1deltacortene 1calaspargase pegol 1azathiopurine 1aldesleukin 1Thioguanine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Asparaginase × 30 days × Clear all
NCT05602194 2026-06-02

Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

Children's Oncology Group

Phase 3 Active not recruiting
440 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡